Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check5 days agoChange DetectedNew version entries dated 2026-09-10 and 2026-09-11 were added to the study record history, including updates to the Study Status and Contacts/Locations sections. The entry dated 2026-03-04 was removed from the history.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry, v3.6.6, has been added to the record history, and the previous revision entry, v3.6.5, has been removed from the list, indicating an update to the version history of the study record.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays the software revision number as v3.6.5, replacing the previous v3.6.4. This reflects a site software update for the page.SummaryDifference0.1%

- Check55 days agoChange DetectedA new software revision tag (v3.6.4) replaces the previous tag (v3.6.3) in the study record history.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.6.3 was added to the history, replacing the previous v3.6.2. This reflects an updated page revision in the study record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe Record History now shows the latest revision as v3.6.2 and removes the previous v3.6.0 entry, updating the page's version label.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.